Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Bhowmick

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Oncotarget|November 21, 2017
Modulation of cabozantinib efficacy by the prostate tumor microenvironmentManisha Tripathi, Srinivas Nandana, Sandrine Billet, et al.
The Journal of Biological Chemistry|January 18, 2015
Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent mannerSubhash Haldar, Christopher Dru, Diptiman Choudhury, et al.
The Prostate|January 1, 2009
Identification of extracellular delta-catenin accumulation for prostate cancer detectionQun Lu, Jiao Zhang, Ron Allison, et al.
Plos One|November 19, 2011
Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasisLin Ge, Matthew Smail, Wenxia Meng, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistanceChuanxia Liu, Sandrine Billet, Diptiman Choudhury, et al.
Cancers|October 7, 2020
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse ModelAhmed F Salem, Luca Gambini, Sandrine Billet, et al.
Oncogene|May 3, 2018
Antagonizing CD105 enhances radiation sensitivity in prostate cancerAnisha Madhav, Allen Andres, Frank Duong, et al.
Endocrine-Related Cancer|June 9, 2020
COVID-19 and androgen-targeted therapy for prostate cancer patientsNeil A Bhowmick, Jillian Oft, Tanya Dorff, et al.
Molecular Cancer Research : MCR|February 1, 2012
Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesionsXiaohong Li, Julie A Sterling, Kang-Hsien Fan, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|January 1, 2025
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesisKuldeep Makwana, Edwin J Velazquez, Diego M Marzese, et al.
Oncotarget|November 21, 2017
Modulation of cabozantinib efficacy by the prostate tumor microenvironmentManisha Tripathi, Srinivas Nandana, Sandrine Billet, et al.
The Journal of Biological Chemistry|January 18, 2015
Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent mannerSubhash Haldar, Christopher Dru, Diptiman Choudhury, et al.
The Prostate|January 1, 2009
Identification of extracellular delta-catenin accumulation for prostate cancer detectionQun Lu, Jiao Zhang, Ron Allison, et al.
Plos One|November 19, 2011
Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasisLin Ge, Matthew Smail, Wenxia Meng, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistanceChuanxia Liu, Sandrine Billet, Diptiman Choudhury, et al.
Cancers|October 7, 2020
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse ModelAhmed F Salem, Luca Gambini, Sandrine Billet, et al.
Oncogene|May 3, 2018
Antagonizing CD105 enhances radiation sensitivity in prostate cancerAnisha Madhav, Allen Andres, Frank Duong, et al.
Endocrine-Related Cancer|June 9, 2020
COVID-19 and androgen-targeted therapy for prostate cancer patientsNeil A Bhowmick, Jillian Oft, Tanya Dorff, et al.
Molecular Cancer Research : MCR|February 1, 2012
Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesionsXiaohong Li, Julie A Sterling, Kang-Hsien Fan, et al.
Pageof 11